Renegades Belmont Stakes Bid Could Shape Horse Racing Betting Market Micron Reaches New Milestone Dicks Earnings and Paxton Triumphs Over Cornyn Morning Market Overview Goldman Sachs Russias Crude Exports Remain Stable Despite Latest US Sanctions Gujarat Government Partners with Meta to Deliver Certificates via WhatsApp Boosting Digital Governance Sindhu Trade Links Surges on Acquisition Plans and Capital Increase Mortgage Rates Fluctuate 30Year Fixed at 634 as Market Eyes Treasury Yields and Geopolitical Risks Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management ANIX Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response VZ Q1 2026 Earnings EPS Beat on Strong Wireless Execution GoPro Q1 2026 Earnings Deep EPS Miss Raises Concerns Amid Modest Stock Gains VRDN Q1 2026 Earnings NarrowerthanExpected Loss as Viridian Advances Clinical Pipeline ETOR Q1 2026 Earnings EPS Surges Past Estimates by 234 Revenue Details Remain Undisclosed Forestar Group Inc FOR Gains Momentum Testing Key Resistance Levels Avidbank Holdings AVBH Shows Modest Uptick as It Approaches Key Resistance Wayfair W Surges 52 as Home Goods Sector Shows Renewed Momentum Huachen AI Parking Management HCAI Slips 32 as Shares Test Key Support Levels Trevi Therapeutics TRVI Shows Potential as Shares Climb Over 2 Healthcare and Tech Lift SP 500 as Communication Services Retreats VSAT Q1 2026 Earnings Strong EPS Surprise Drives Shares Higher BRC Group Holdings RILY Nears Key Support After Steady Decline First Watch FWRG Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction CV Q1 2026 Earnings EPS Misses Estimates as Company Reports Wider Loss Runway Growth Finance Corp Q1 2026 Earnings EPS Misses Estimates Amid Stable Portfolio Performance SCNX Q1 2026 Earnings Narrowerthanexpected loss drives positive surprise despite revenue absence MNDO Q1 2025 Earnings EPS of 002 Reported as Stock Rises 133 PDEX Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction ANNX Q1 2026 Earnings EPS Beat Surprise as ClinicalStage Biotech Tightens Cost Control